NMS-859
CAS No. 1449236-96-7
NMS-859 ( ZINC169324353 )
产品货号. M26335 CAS No. 1449236-96-7
NMS-859 is an effective and covalent inhibitor of valosin-containing protein (VCP)/p97 with IC50s of 0.37 μM and 0.36 μM for wild-type VCP in the presence of 60 μM and 1 mM ATP in cells, respectively.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥1839 | 有现货 |
|
5MG | ¥2811 | 有现货 |
|
10MG | ¥4026 | 有现货 |
|
25MG | ¥6423 | 有现货 |
|
50MG | ¥9153 | 有现货 |
|
100MG | ¥12312 | 有现货 |
|
500MG | ¥24057 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称NMS-859
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述NMS-859 is an effective and covalent inhibitor of valosin-containing protein (VCP)/p97 with IC50s of 0.37 μM and 0.36 μM for wild-type VCP in the presence of 60 μM and 1 mM ATP in cells, respectively.
-
产品描述NMS-859 is an effective and covalent inhibitor of valosin-containing protein (VCP)/p97 with IC50s of 0.37 μM and 0.36 μM for wild-type VCP in the presence of 60 μM and 1 mM ATP in cells, respectively.(In Vitro):NMS-859 suppresses the cell proliferation with IC50s of 3.0 μM and 3.5 μM in HeLa and HCT116 cell lines, respectively. NMS-859 shows weak inhibitory activity against VCPC522T.
-
同义词ZINC169324353
-
通路Others
-
靶点Other Targets
-
受体ADC Cytotoxin; Microtubule/Tubulin
-
研究领域——
-
适应症——
化学信息
-
CAS Number1449236-96-7
-
分子量349.8
-
分子式C15H12ClN3O3S
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESClCC(=O)Nc1cccc(NC2=NS(=O)(=O)c3ccccc23)c1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Francisco JA, et al. cAC10-vcMMAE, an anti-CD30-monomethyl auristatin E conjugate with potent and selective antitumor activity. Blood. 2003 Aug 15;102(4):1458-65.
产品手册
关联产品
-
KN-92 phosphate
KN-92 is an inactive derivative of KN-93. KN-93 is a selective inhibitor of Ca2+/calmodulin-dependent kinase II (CaMKII).
-
Methyl nomilinate
Methyl nomilinate from citrus can modulate cell cycle regulators to induce cytotoxicity in human colon cancer (SW480) cells in vitro.
-
Methyl nomilinate
Methyl nomilinate from citrus can modulate cell cycle regulators to induce cytotoxicity in human colon cancer (SW480) cells in vitro.